Abstract
Get full access to this article
View all access options for this article.
References
1.Policy impact: Prescription painkiller overdoses. Centers for Disease Control and Prevention. http://www.cdc.gov/home-andrecreationalsafety/rxbrief/. Accessed February 13, 2015.
2.US Department of Health and Human Services . National Institutes of Health. Prescription opioid and heroin abuse. Testimony by Nora Volkow, MD. Director, National Institute on Drug Abuse. http://democrats.energycommerce.house.gov/sites/default/files/documents/Testimony-Nora-Volkow-OI-Prescription-Drug-and-Heroin-Abuse-2014-4-29.pdf. Accessed February 13, 2015.
3.Prescription drug monitoring frequently asked questions . The PDMP Training and Technical Assistance Center. http://www.pdmpassist.org/content/prescription-drug-monitoring-frequently-asked-questions-faq. Accessed February 13, 2015.
4.State PDMP Web sites . The PDMP Training and Technical Assistance Center. http://www.pdmpassist.org/content/state-pdmp-websites. Accessed February 13, 2015.
5.Prescription drug monitoring program - bill status update . National Alliance for Model State Drug Laws. http://www.namsdl.org/prescription-monitoring-programs.cfm. Accessed February 13, 2015.
6.State prescription drug monitoring programs . Questions and answers. US Department of Justice. http://www.deadiversion.usdoj.gov/faq/rx_monitor.htm. Accessed February 13, 2015.
7.
Shepherd J.
Combating the prescription drug painkiller epidemic: A national prescription drug reporting program . Am J Law Med. 2014 ; 40 (1 ): 85 –112 .